2024 Q2 Form 10-Q Financial Statement

#000082241624000016 Filed on April 23, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $4.600B $3.949B
YoY Change 9.81% 10.45%
Cost Of Revenue $3.156B $2.778B
YoY Change 7.52% 9.29%
Gross Profit $1.443B $1.172B
YoY Change 15.18% 13.28%
Gross Profit Margin 31.38% 29.67%
Selling, General & Admin $361.1M $357.6M
YoY Change 14.78% 6.26%
% of Gross Profit 25.02% 30.52%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $21.83M $21.06M
YoY Change 8.8% 10.04%
% of Gross Profit 1.51% 1.8%
Operating Expenses $361.1M $354.1M
YoY Change 14.74% 5.23%
Operating Profit $1.082B $817.5M
YoY Change 15.32% 17.16%
Interest Expense $19.19M $55.17M
YoY Change 19.01% 480.57%
% of Operating Profit 1.77% 6.75%
Other Income/Expense, Net $13.32M $16.68M
YoY Change -1.93% 817.66%
Pretax Income $1.048B $868.6M
YoY Change 10.0% 23.72%
Income Tax $239.2M $205.7M
% Of Pretax Income 22.82% 23.68%
Net Earnings $809.1M $663.0M
YoY Change 12.71% 24.56%
Net Earnings / Revenue 17.59% 16.79%
Basic Earnings Per Share $3.86 $3.13
Diluted Earnings Per Share $3.83 $3.11
COMMON SHARES
Basic Shares Outstanding 210.3M shares 212.1M shares
Diluted Shares Outstanding 211.2M shares 213.5M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.393B $1.720B
YoY Change -19.43% 34.55%
Cash & Equivalents $1.393B $1.720B
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $12.30B $12.11B
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $13.70B $13.83B
YoY Change 4.83% 8.79%
LONG-TERM ASSETS
Property, Plant & Equipment $73.80M $76.50M
YoY Change 1.1% 4.94%
Goodwill $68.93M $68.93M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $210.2M $775.0M
YoY Change -63.99% 435.69%
Other Assets $128.9M $133.3M
YoY Change -15.37% -24.34%
Total Long-Term Assets $2.849B $2.669B
YoY Change 31.76% 25.85%
TOTAL ASSETS
Total Short-Term Assets $13.70B $13.83B
Total Long-Term Assets $2.849B $2.669B
Total Assets $16.54B $16.50B
YoY Change 8.66% 11.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $651.6M $575.1M
YoY Change 19.9% 17.66%
Accrued Expenses $1.460B $1.632B
YoY Change -4.95% -2.56%
Deferred Revenue
YoY Change
Short-Term Debt $524.0M $534.3M
YoY Change 66.06% 64.69%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.290B $3.441B
YoY Change 3.06% 4.74%
LONG-TERM LIABILITIES
Long-Term Debt $1.650B $1.957B
YoY Change -18.84% -4.15%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.650B $1.957B
YoY Change -18.84% -4.15%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.290B $3.441B
Total Long-Term Liabilities $1.650B $1.957B
Total Liabilities $5.321B $5.734B
YoY Change -3.62% 3.0%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.22B $10.76B
YoY Change
Total Liabilities & Shareholders Equity $16.54B $16.50B
YoY Change 8.66% 11.23%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $809.1M $663.0M
YoY Change 12.71% 24.56%
Depreciation, Depletion And Amortization $21.83M $21.06M
YoY Change 8.8% 10.04%
Cash From Operating Activities $417.5M $239.8M
YoY Change -43.52% -66.29%
INVESTING ACTIVITIES
Capital Expenditures $31.24M $24.08M
YoY Change 46.44% 1.4%
Acquisitions
YoY Change
Other Investing Activities -$8.071M -$2.813M
YoY Change -4.47% -279.17%
Cash From Investing Activities -$39.31M -$26.89M
YoY Change 32.0% 11.05%
FINANCING ACTIVITIES
Cash Dividend Paid $42.68M
YoY Change 17.33%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $11.14M
YoY Change 147.56%
Cash From Financing Activities -698.3M -296.0M
YoY Change 170.12% -34.93%
NET CHANGE
Cash From Operating Activities 417.5M 239.8M
Cash From Investing Activities -39.31M -26.89M
Cash From Financing Activities -698.3M -296.0M
Net Change In Cash -320.1M -83.09M
YoY Change -170.99% -135.77%
FREE CASH FLOW
Cash From Operating Activities $417.5M $239.8M
Capital Expenditures $31.24M $24.08M
Free Cash Flow $386.2M $215.7M
YoY Change -46.2% -68.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Revenues
Revenues
3949160000 usd
CY2023Q1 us-gaap Revenues
Revenues
3575641000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2726130000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2497296000 usd
CY2024Q1 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
51378000 usd
CY2023Q1 us-gaap Other Cost Of Operating Revenue
OtherCostOfOperatingRevenue
44036000 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
357594000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
336518000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
37902000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2513000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
16683000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1818000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
868643000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
702122000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
205667000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
169863000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
662976000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
532259000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.13
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.35
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.10
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.35
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.20
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.16
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
211837000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
225127000 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1709000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
830000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
213546000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
225957000 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
10383257000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
9292000 usd
CY2024Q1 us-gaap Dividends
Dividends
42609000 usd
CY2024Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
245844000 usd
CY2024Q1 phm Excise Tax On Share Repurchase
ExciseTaxOnShareRepurchase
2031000 usd
CY2024Q1 phm Excise Tax On Share Repurchase
ExciseTaxOnShareRepurchase
2031000 usd
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
17592000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14504000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
662976000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
10761953000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
8914098000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4842000 usd
CY2023Q1 us-gaap Dividends
Dividends
36139000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
150000000 usd
CY2023Q1 phm Excise Tax On Share Repurchase
ExciseTaxOnShareRepurchase
1221000 usd
CY2023Q1 phm Excise Tax On Share Repurchase
ExciseTaxOnShareRepurchase
1221000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
10059000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10029000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
532259000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
9263809000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
662976000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
532259000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
37428000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
28152000 usd
CY2024Q1 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
4018000 usd
CY2023Q1 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
5683000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
21061000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
19139000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
37902000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2513000 usd
CY2024Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
1256000 usd
CY2023Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
3509000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
16585000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
12488000 usd
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
413000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-50000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
289247000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
85408000 usd
CY2024Q1 us-gaap Increase Decrease In Mortgage Loans Held For Sale
IncreaseDecreaseInMortgageLoansHeldForSale
54774000 usd
CY2023Q1 us-gaap Increase Decrease In Mortgage Loans Held For Sale
IncreaseDecreaseInMortgageLoansHeldForSale
-256360000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
108132000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-25053000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-13069000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-83404000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
239787000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
711368000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24076000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
23743000 usd
CY2024Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
3955000 usd
CY2023Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
1117000 usd
CY2024Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
3398000 usd
CY2023Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
2216000 usd
CY2024Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
2256000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1570000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-26889000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-24214000 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
11140000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
4500000 usd
CY2024Q1 us-gaap Proceeds From Repayments Of Other Debt
ProceedsFromRepaymentsOfOtherDebt
34708000 usd
CY2023Q1 us-gaap Proceeds From Repayments Of Other Debt
ProceedsFromRepaymentsOfOtherDebt
-262264000 usd
CY2024Q1 phm Proceeds Land Under Purchase Options Recorded
ProceedsLandUnderPurchaseOptionsRecorded
19077000 usd
CY2023Q1 phm Proceeds Land Under Purchase Options Recorded
ProceedsLandUnderPurchaseOptionsRecorded
18449000 usd
CY2024Q1 phm Payments Land Under Purchase Options Recorded
PaymentsLandUnderPurchaseOptionsRecorded
32511000 usd
CY2023Q1 phm Payments Land Under Purchase Options Recorded
PaymentsLandUnderPurchaseOptionsRecorded
10099000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
245844000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
150000000 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
17592000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
10059000 usd
CY2024Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
42684000 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
36380000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-295986000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-454853000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-83088000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
232301000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1849177000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1094553000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1766089000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1326854000 usd
CY2024Q1 phm Interestpaidcapitalizednet
Interestpaidcapitalizednet
7251000 usd
CY2023Q1 phm Interestpaidcapitalizednet
Interestpaidcapitalizednet
6205000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1015000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
209000 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of estimates</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</span></div>
CY2024Q1 phm Write Off Of Deposits And Pre Acquisition Costs
WriteOffOfDepositsAndPreAcquisitionCosts
3990000 usd
CY2023Q1 phm Write Off Of Deposits And Pre Acquisition Costs
WriteOffOfDepositsAndPreAcquisitionCosts
5683000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2540000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2670000 usd
CY2024Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-64000 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2024Q1 us-gaap Interest Income Other
InterestIncomeOther
17379000 usd
CY2023Q1 us-gaap Interest Income Other
InterestIncomeOther
7096000 usd
CY2024Q1 us-gaap Interest Expense Other
InterestExpenseOther
115000 usd
CY2023Q1 us-gaap Interest Expense Other
InterestExpenseOther
107000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6013000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3182000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
16683000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1818000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
698800000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
675100000 usd
CY2024Q1 phm Contractassetinsurancerenewals
Contractassetinsurancerenewals
77800000 usd
CY2023Q4 phm Contractassetinsurancerenewals
Contractassetinsurancerenewals
74000000 usd
CY2024Q1 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
570800000 usd
CY2023Q4 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
516100000 usd
CY2024Q1 us-gaap Inventory Real Estate Mortgage Loans Held In Inventory
InventoryRealEstateMortgageLoansHeldInInventory
573700000 usd
CY2023Q4 us-gaap Inventory Real Estate Mortgage Loans Held In Inventory
InventoryRealEstateMortgageLoansHeldInInventory
508500000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
50600000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
20600000 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts
FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit losses</span></div>We are exposed to credit losses primarily through our vendors and insurance carriers. We assess and monitor each counterparty’s ability to pay amounts owed by considering contractual terms and conditions, the counterparty’s financial condition, macroeconomic factors, and business strategy. Our
CY2024Q1 us-gaap Maximum Length Of Time Hedged In Cash Flow Hedge1
MaximumLengthOfTimeHedgedInCashFlowHedge1
P90D
CY2024Q1 us-gaap Derivative Instruments In Hedges Assets At Fair Value
DerivativeInstrumentsInHedgesAssetsAtFairValue
8308000 usd
CY2024Q1 us-gaap Derivative Instruments In Hedges Liabilities At Fair Value
DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
15927000 usd
CY2023Q4 us-gaap Derivative Instruments In Hedges Assets At Fair Value
DerivativeInstrumentsInHedgesAssetsAtFairValue
4060000 usd
CY2023Q4 us-gaap Derivative Instruments In Hedges Liabilities At Fair Value
DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
27657000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
532259000 usd
CY2023Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
126000 usd
CY2023Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
2148000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
529985000 usd
CY2023Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
2148000 usd
CY2023Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
2135000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
529998000 usd
CY2024Q1 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
5589782000 usd
CY2023Q4 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
5262850000 usd
CY2024Q1 us-gaap Land Available For Development
LandAvailableForDevelopment
5865321000 usd
CY2023Q4 us-gaap Land Available For Development
LandAvailableForDevelopment
5805993000 usd
CY2024Q1 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
546215000 usd
CY2023Q4 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
606005000 usd
CY2024Q1 phm Inventory Real Estate Not Owned
InventoryRealEstateNotOwned
105894000 usd
CY2023Q4 phm Inventory Real Estate Not Owned
InventoryRealEstateNotOwned
120522000 usd
CY2024Q1 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
12107212000 usd
CY2023Q4 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
11795370000 usd
CY2023Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
139078000 usd
CY2022Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
137262000 usd
CY2024Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
30620000 usd
CY2023Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
31802000 usd
CY2024Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
21597000 usd
CY2023Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
27793000 usd
CY2024Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
148101000 usd
CY2023Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
141271000 usd
CY2024Q1 us-gaap Purchase Options Land
PurchaseOptionsLand
792800000 usd
CY2024Q1 phm Remaining Purchase Price Of All Land Option Agreements
RemainingPurchasePriceOfAllLandOptionAgreements
6679602000 usd
CY2023Q4 us-gaap Purchase Options Land
PurchaseOptionsLand
704209000 usd
CY2023Q4 phm Remaining Purchase Price Of All Land Option Agreements
RemainingPurchasePriceOfAllLandOptionAgreements
6448124000 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
6 segment
CY2024Q1 us-gaap Revenues
Revenues
3949160000 usd
CY2023Q1 us-gaap Revenues
Revenues
3575641000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
868643000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
702122000 usd
CY2024Q1 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
37700000 usd
CY2024Q1 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
4018000 usd
CY2023Q1 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
5683000 usd
CY2024Q1 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
5589782000 usd
CY2024Q1 us-gaap Land Available For Development
LandAvailableForDevelopment
5865321000 usd
CY2024Q1 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
546215000 usd
CY2024Q1 phm Inventory Real Estate Not Owned
InventoryRealEstateNotOwned
105894000 usd
CY2024Q1 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
12107212000 usd
CY2024Q1 us-gaap Assets
Assets
16496230000 usd
CY2023Q4 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
5262850000 usd
CY2023Q4 us-gaap Land Available For Development
LandAvailableForDevelopment
5805993000 usd
CY2023Q4 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
606005000 usd
CY2023Q4 phm Inventory Real Estate Not Owned
InventoryRealEstateNotOwned
120522000 usd
CY2023Q4 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
11795370000 usd
CY2023Q4 us-gaap Assets
Assets
16087050000 usd
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
7693000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
8047000 usd
CY2024Q1 us-gaap Senior Notes
SeniorNotes
1881451000 usd
CY2023Q4 us-gaap Senior Notes
SeniorNotes
1891252000 usd
CY2024Q1 us-gaap Other Notes Payable
OtherNotesPayable
75403000 usd
CY2023Q4 us-gaap Other Notes Payable
OtherNotesPayable
70966000 usd
CY2023Q4 us-gaap Other Notes Payable
OtherNotesPayable
70966000 usd
CY2024Q1 us-gaap Notes Payable
NotesPayable
1956854000 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
1962218000 usd
CY2024Q1 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
2045752000 usd
CY2023Q4 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
2080187000 usd
CY2024Q1 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
1300000000 usd
CY2024Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
1800000000 usd
CY2024Q1 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2024Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
298600000 usd
CY2024Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
951400000 usd
CY2023Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
312700000 usd
CY2023Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
937300000 usd
CY2024Q1 us-gaap Dividends
Dividends
42600000 usd
CY2023Q1 us-gaap Dividends
Dividends
36100000 usd
CY2024Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
1500000000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.237
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.242
CY2024Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
274800000 usd
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
237400000 usd
CY2024Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
58200000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
58200000 usd
CY2024Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
7000000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
6300000 usd
CY2024Q1 us-gaap Other Notes Payable
OtherNotesPayable
75403000 usd
CY2023Q4 us-gaap Other Notes Payable
OtherNotesPayable
70966000 usd
CY2023Q4 us-gaap Other Notes Payable
OtherNotesPayable
70966000 usd
CY2023Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
563100000 usd
CY2024Q1 phm Incurred But Not Reported Percentage Of Liability Reserves
IncurredButNotReportedPercentageOfLiabilityReserves
0.77
CY2023Q4 phm Incurred But Not Reported Percentage Of Liability Reserves
IncurredButNotReportedPercentageOfLiabilityReserves
0.77
CY2024Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
298600000 usd
CY2024Q1 phm Surety Bonds Outstanding
SuretyBondsOutstanding
2600000000 usd
CY2023Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
312700000 usd
CY2023Q4 phm Surety Bonds Outstanding
SuretyBondsOutstanding
2400000000 usd
CY2024Q1 phm Comprehensive Limited Warranty Against Building Defects
ComprehensiveLimitedWarrantyAgainstBuildingDefects
P1Y
CY2024Q1 phm Maximum Product Warranty In Years
MaximumProductWarrantyInYears
P10Y
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
120393000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
108348000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
26741000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
20371000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
24834000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
24134000 usd
CY2024Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
442000 usd
CY2023Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
1395000 usd
CY2024Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
122742000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
105980000 usd
CY2024Q1 us-gaap Self Insurance Reserve
SelfInsuranceReserve
547600000 usd
CY2023Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
563103000 usd
CY2022Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
635857000 usd
CY2024Q1 phm Additions To Self Insurance Reserves
AdditionsToSelfInsuranceReserves
19966000 usd
CY2023Q1 phm Additions To Self Insurance Reserves
AdditionsToSelfInsuranceReserves
24121000 usd
CY2024Q1 us-gaap Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
-26845000 usd
CY2023Q1 us-gaap Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
-564000 usd
CY2024Q1 us-gaap Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
8603000 usd
CY2023Q1 us-gaap Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
6669000 usd
CY2024Q1 us-gaap Self Insurance Reserve
SelfInsuranceReserve
547621000 usd
CY2023Q1 us-gaap Self Insurance Reserve
SelfInsuranceReserve
652745000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
76500000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
90300000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
77400000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
91600000 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3700000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3900000 usd
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
5900000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
5400000 usd
CY2024Q1 us-gaap Lease Cost
LeaseCost
15000000 usd
CY2023Q1 us-gaap Lease Cost
LeaseCost
14200000 usd
CY2024Q1 us-gaap Variable Lease Cost
VariableLeaseCost
3600000 usd
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
3000000 usd
CY2024Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
4800000 usd
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
4200000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
21115000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
22392000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
16542000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
12968000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
10381000 usd
CY2024Q1 phm Lessee Operating Lease Liabilitytobe Paidafter Year Four
LesseeOperatingLeaseLiabilitytobePaidafterYearFour
16151000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
99549000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
9257000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
90292000 usd
CY2024Q1 phm Lessee Operating Lease Lease Not Yet Commenced Liability
LesseeOperatingLeaseLeaseNotYetCommencedLiability
33600000 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.040
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0000822416-24-000016-index-headers.html Edgar Link pending
0000822416-24-000016-index.html Edgar Link pending
0000822416-24-000016.txt Edgar Link pending
0000822416-24-000016-xbrl.zip Edgar Link pending
exhibit31aceocertification.htm Edgar Link pending
exhibit31bcfocertification.htm Edgar Link pending
exhibit32-certification033.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
phm-20240331.htm Edgar Link pending
phm-20240331.xsd Edgar Link pending
phm-20240331_g1.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
phm-20240331_cal.xml Edgar Link unprocessable
phm-20240331_def.xml Edgar Link unprocessable
phm-20240331_lab.xml Edgar Link unprocessable
phm-20240331_pre.xml Edgar Link unprocessable
phm-20240331_htm.xml Edgar Link completed
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending